Possible atomoxetine-induced vitiligo: a case report

dc.contributor.authorBilgic, Ozlem
dc.contributor.authorBilgic, Ayhan
dc.date.accessioned2024-02-23T13:59:56Z
dc.date.available2024-02-23T13:59:56Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractVitiligo is a chronic skin disease characterized by the appearance of white depigmented lesion due to a loss of melanocytes. The etiopathogenesis of vitiligo is not clear, but according to the neural theory of vitiligo, the direct and indirect effects of monoamine neurotransmitters cause melanocyte destruction and various studies have supported this theory. Many drugs have been related to the development of vitiligo, and the melanocytotoxic effects of the some of these drugs are thought to be related due to their effects on the monoaminergic system. Furthermore, a recent article reported the development of a localized loss of pigmentation after the application of a methylphenidate patch in a patient with attention-deficit/hyperactivity disorder (ADHD). Atomoxetine is an inhibitor of norepinephrine reuptake sites and is a drug that has been used for the treatment of ADHD. Here, we present a school-aged child with ADHD who displayed a vitiligo lesion following the initiation of atomoxetine. We further discuss the possible impact of the ADHD drugs on the development of vitiligo.en_US
dc.identifier.doi10.1007/s12402-015-0166-1
dc.identifier.endpage181en_US
dc.identifier.issn1866-6116
dc.identifier.issn1866-6647
dc.identifier.issue3en_US
dc.identifier.pmid25605459en_US
dc.identifier.scopus2-s2.0-84940435026en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage179en_US
dc.identifier.urihttps://doi.org/10.1007/s12402-015-0166-1
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11376
dc.identifier.volume7en_US
dc.identifier.wosWOS:000360295800002en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Wienen_US
dc.relation.ispartofAdhd-Attention Deficit And Hyperactivity Disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAtomoxetineen_US
dc.subjectVitiligoen_US
dc.subjectNorepinephrineen_US
dc.subjectNeural Theoryen_US
dc.titlePossible atomoxetine-induced vitiligo: a case reporten_US
dc.typeArticleen_US

Dosyalar